Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography.


We evaluated the feasibility of 99Tcm-methoxyisobutylisonitrile (MIBI) as a tumour localizing agent in patients with palpable breast masses in comparison with mammography and ultrasonography (US). Forty-one patients with palpable masses were studied. An additional 12 women with no palpable breast anomaly also underwent 99Tcm-MIBI breast study. Multiple… (More)


  • Presentations referencing similar topics